Table of Contents
Managing blood glucose levels is essential for individuals with Type 1 Diabetes to maintain health and prevent complications. Stringent glycemic control with intensive insulin therapy can prevent or postpone progression of microvascular disease and reduce the risk for macrovascular disease and all-cause mortality. Implementing effective strategies can help achieve stable blood sugar and improve quality of life for those living with this autoimmune condition.
Understanding Type 1 Diabetes and Blood Glucose Management
Type 1 diabetes is an autoimmune disease characterized by progressive pancreatic beta-cell loss resulting in insulin deficiency and hyperglycemia. Exogenous insulin therapy is essential to prevent fatal complications from hyperglycemia. Approximately 1.6 million Americans are living with Type 1 diabetes as of 2025, making effective management strategies crucial for this population.
Insulin management today is more personalized and adaptive than ever before. The landscape of Type 1 diabetes care has evolved significantly from fixed regimens and manual glucose checks to dynamic, data-driven tools that enable better outcomes and enhanced quality of life.
Continuous Glucose Monitoring: The New Standard of Care
What Is Continuous Glucose Monitoring?
A CGM is a wearable medical device that works by having a small, removable sensor placed just under the skin measure glucose levels in real time and send alerts when they are outside a target range. Unlike traditional fingerstick tests which provide periodic infrequent snapshots of blood sugar levels, CGMs measure glucose levels every five minutes, allowing individuals to understand glucose trends and patterns throughout the day and night.
There is a tiny sensor that can be inserted under your skin, often the skin on your belly or arm, with a sticky patch that helps it stay there, called disposable sensors, while another type called an implantable sensor may be placed inside your body. CGM sensors estimate the glucose level in the fluid between your cells, which is very similar to the glucose level in your blood.
Clinical Benefits of CGM Technology
Continuous glucose monitoring improves outcomes with injected or infused insulin and is superior to blood glucose monitoring. The clinical evidence supporting CGM use in Type 1 diabetes is substantial and continues to grow.
CGM has demonstrated substantial improvements in glycemic control across multiple metrics, with studies reporting consistent glycosylated hemoglobin reductions of 0.25%–3.0% and notable time in range improvements of 15%–34%. CGM effectively reduces hypoglycemic events, with studies reporting significant reductions in time spent in hypoglycemia.
Type 1 diabetes management has been revolutionized with the development and routine utilization of continuous glucose monitoring, allowing for the ability to track dynamic glycemic fluctuations and trends over time allowing for optimization of medical therapy and the prevention of dangerous hypoglycemic events.
Real-World Benefits for Patients and Families
Families reported the following as benefits of CGM: pain relief, better hypoglycemia and hyperglycemia management, increased control over diet and social life, reduced worries at school and during the night, and convenience in entrusting the child to the care of others.
One advantage of using a CGM or glucose monitoring device is the continuous tracking which provides a comprehensive view of blood glucose levels, helping people with diabetes better understand how their bodies respond to food, physical activity, and medication. CGMs also help reduce the risk of low blood glucose and high blood glucose by providing real-time alerts when glucose levels are out of range, allowing for timely intervention and preventing dangerous glucose level fluctuations.
Current CGM Recommendations
The ADA SOC 2025 recommends CGM for all individuals with Type 1 diabetes and those with Type 2 diabetes on insulin, and it is also strongly recommended for pregnant individuals, older adults at risk for hypoglycemia, and children from the time of diagnosis. The people who benefit the most from a CGM are those who use it every day or nearly every day.
Disposable CGM sensors should be replaced every 7 to 14 days depending on the model, while some implantable sensors can last up to 180 days. Understanding the maintenance requirements helps ensure consistent and accurate glucose monitoring.
Advanced Insulin Management Strategies
Understanding Insulin Requirements
Insulin therapy using rapid- and long-acting insulin analogs is the mainstay of management of T1D, with insulin delivery achieved subcutaneously using multiple daily injections or subcutaneous insulin infusion using insulin pumps. Proper insulin administration is crucial for blood sugar control and requires understanding individual needs and patterns.
Total daily insulin requirements can be estimated based on weight, with typical doses ranging from 0.4 to 1 unit/kg/day. Higher amounts may be required during puberty, menses, and medical illness. The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook notes 0.5 units/kg/day as a typical starting dose in adults with type 1 diabetes who are metabolically stable.
Basal and Prandial Insulin Balance
Typical multidose treatment plans for individuals with type 1 diabetes combine premeal use of prandial insulins with a longer-acting formulation, with the long-acting basal dose titrated to regulate overnight and fasting glucose. In general, individuals with type 1 diabetes require approximately 30–50% of their daily insulin as basal and the remainder as prandial.
Postprandial glucose excursions are best managed by a well-timed injection or inhalation of prandial insulin, with prandial insulin ideally administered prior to meal consumption, though the optimal time to administer varies based on the pharmacokinetics of the formulation, the premeal blood glucose level, and carbohydrate consumption. Recommendations for prandial insulin dose administration should therefore be individualized.
Multiple Daily Injections vs. Insulin Pump Therapy
A simpler conceptual approach preferred by most patients with T1D is using a prandial insulin analog for each meal and a separate basal insulin analog, and although these true basal-prandial regimens require more shots than conventional twice-daily regimens, they are considerably more flexible, allowing greater freedom to skip meals or change mealtimes.
A systematic review and meta-analysis concluded that CSII via pump therapy has modest advantages for lowering A1C and for reducing severe hypoglycemia rates in children and adults. Using insulin pumps or multiple daily injections can offer flexibility and precision based on individual lifestyle needs and preferences.
Ultra-Rapid-Acting Insulin Analogs
Ultra-rapid-acting insulin analogs like Fiasp (faster-acting insulin aspart) have significantly reduced the postprandial glucose spike. These newer formulations provide additional options for managing post-meal blood sugar excursions more effectively, particularly for individuals who experience rapid glucose rises after eating.
Automated Insulin Delivery Systems
The Artificial Pancreas Revolution
An artificial pancreas, also called an automated insulin delivery system (AID), mimics how a healthy pancreas controls blood glucose in the body, with a CGM, an insulin pump, and a software program that shares information between the CGM and insulin pump making up the artificial pancreas. The artificial pancreas is mainly used to help people with type 1 diabetes keep their glucose levels in their target range.
The CGM estimates glucose levels and wirelessly sends the information to a software program on a smartphone or insulin pump, the program calculates how much insulin your body needs and the insulin pump delivers the insulin when glucose levels rise higher than your target range, and if your glucose levels fall lower than your target range, the artificial pancreas can lower or stop the amount of insulin given by the insulin pump.
Hybrid Closed-Loop Systems
One of the most promising developments is the rise of hybrid closed-loop systems, commonly referred to as artificial pancreas technology, with devices like the Medtronic MiniMed 780G and Tandem t:slim X2 with Control-IQ combining continuous glucose monitoring with automated insulin delivery, reducing the burden of daily management while improving Time in Range metrics.
According to a 2024 study published in The Lancet Diabetes & Endocrinology, patients using closed-loop systems had a 20% improvement in TIR compared to those on traditional pump therapy. Automated systems like Tandem Control-IQ and Omnipod 5 lead the way, offering real-time glucose-driven insulin adjustments.
Benefits of Automated Insulin Delivery
CGM sensors that are integrated with AID systems automatically adjust insulin delivery based on glucose readings, potentially reducing glycemic variability and improving overall diabetes management. These systems represent a significant advancement in reducing the cognitive burden of diabetes management while improving outcomes.
Automated insulin delivery systems work continuously throughout the day and night, making micro-adjustments to insulin delivery that would be impossible to achieve manually. This technology is particularly beneficial during sleep when individuals cannot actively monitor their glucose levels or make insulin adjustments.
Carbohydrate Counting and Nutrition Management
The Importance of Carbohydrate Awareness
Eating a balanced diet with consistent carbohydrate intake helps stabilize blood glucose levels. Carbohydrate counting is a meal planning technique that helps individuals with Type 1 diabetes match their insulin doses to the amount of carbohydrates consumed. This approach provides flexibility in food choices while maintaining good glycemic control.
Physiologic insulin secretion varies with glycemia, meal size, meal composition, and tissue demand for glucose, and to address this variability in people treated with insulin, strategies have evolved to adjust prandial doses based on predicted needs. Understanding how different foods affect blood glucose is essential for effective diabetes management.
Insulin-to-Carbohydrate Ratios
The insulin-to-carbohydrate ratio (ICR) determines how many grams of carbohydrate are covered by one unit of rapid-acting insulin. This ratio is individualized and may vary throughout the day. For example, someone might need 1 unit of insulin for every 10 grams of carbohydrate at breakfast but 1 unit for every 15 grams at dinner.
Working with a certified diabetes care and education specialist or registered dietitian can help establish accurate insulin-to-carbohydrate ratios. These ratios should be periodically reassessed and adjusted based on blood glucose patterns and lifestyle changes.
Fiber-Rich Foods and Glycemic Impact
Incorporating fiber-rich foods into the diet can help moderate blood glucose responses. Foods high in soluble fiber, such as oats, beans, lentils, and certain fruits, slow down carbohydrate absorption and can lead to more gradual blood glucose rises. This can make post-meal glucose management easier and reduce the risk of both hyperglycemia and subsequent hypoglycemia.
Whole grains, vegetables, nuts, and seeds provide essential nutrients while supporting stable blood glucose levels. Choosing complex carbohydrates over simple sugars helps prevent rapid glucose spikes and provides sustained energy throughout the day.
Understanding the Glycemic Index
The glycemic index (GI) ranks carbohydrate-containing foods based on how quickly they raise blood glucose levels. Low-GI foods cause a slower, more gradual rise in blood glucose, while high-GI foods cause rapid spikes. Incorporating more low-GI foods into meals can improve overall glycemic control and reduce glucose variability.
Examples of low-GI foods include most non-starchy vegetables, legumes, whole grain pasta, and certain fruits like apples and berries. High-GI foods include white bread, white rice, potatoes, and sugary snacks. Understanding these differences helps in making informed food choices.
Protein and Fat Considerations
While carbohydrates have the most immediate impact on blood glucose, protein and fat also play important roles in diabetes management. Large amounts of protein can be converted to glucose through gluconeogenesis, potentially affecting blood sugar hours after eating. High-fat meals can delay carbohydrate absorption and lead to prolonged elevation of blood glucose.
For meals high in both carbohydrates and fat, such as pizza, individuals using insulin pumps may benefit from extended or dual-wave boluses that deliver insulin over a longer period. Those using multiple daily injections might need to split their mealtime insulin dose or take additional corrections later.
Real-Time Feedback from CGM
CGM also serves as an educational tool for lifestyle modification, providing real-time feedback that helps patients understand how diet and physical activity affect glucose levels. Parents noted that they can observe and understand the effects of foods separately and how they increase glucose levels, with just 15 minutes after meals being able to see the course of the food.
This immediate feedback allows individuals to learn which foods work best for their body and make informed decisions about portion sizes, meal timing, and insulin dosing. Over time, this knowledge becomes intuitive and supports better long-term management.
Physical Activity and Exercise Management
Benefits of Regular Exercise
Regular exercise improves insulin sensitivity and helps regulate blood sugar levels. Physical activity offers numerous benefits for individuals with Type 1 diabetes, including improved cardiovascular health, better weight management, enhanced mood, and increased energy levels. Exercise also helps improve insulin sensitivity, meaning the body can use insulin more effectively.
Both aerobic exercise (such as walking, running, swimming, or cycling) and resistance training (such as weightlifting) provide benefits. A combination of both types of exercise is ideal for overall health and diabetes management. The American Diabetes Association recommends at least 150 minutes of moderate-intensity aerobic activity per week, spread over at least three days.
Monitoring Glucose During Exercise
It is important to monitor blood glucose before, during, and after activity to prevent hypoglycemia or hyperglycemia. Different types of exercise affect blood glucose in different ways. Aerobic exercise typically lowers blood glucose during and after activity, while high-intensity interval training or competitive sports may initially raise blood glucose due to stress hormone release.
Checking glucose levels before exercise helps determine whether it’s safe to begin. If glucose is below 90 mg/dL, consuming 15-30 grams of carbohydrate before starting can help prevent hypoglycemia. If glucose is above 250 mg/dL with ketones present, exercise should be postponed until glucose levels improve.
Adjusting Insulin for Physical Activity
Insulin adjustments may be necessary before, during, or after exercise to maintain stable blood glucose levels. For planned exercise, reducing basal insulin rates (for pump users) or the pre-exercise meal bolus can help prevent hypoglycemia. Some individuals may need to reduce basal insulin several hours before exercise or use temporary basal rate reductions.
For spontaneous or unplanned activity, consuming additional carbohydrates without extra insulin may be necessary. The amount needed depends on the intensity and duration of exercise, current glucose levels, and individual response patterns. Keeping fast-acting carbohydrates readily available during exercise is essential for treating hypoglycemia if it occurs.
Post-Exercise Glucose Management
Blood glucose can continue to drop for several hours after exercise as muscles replenish glycogen stores. This delayed hypoglycemia is particularly common after prolonged or intense exercise. Monitoring glucose levels closely for 12-24 hours after significant physical activity helps identify and prevent late-onset hypoglycemia.
Some individuals may need to reduce overnight basal insulin or consume a bedtime snack after evening exercise. CGM technology with predictive low glucose alerts can be particularly helpful in detecting and preventing post-exercise hypoglycemia during sleep.
Exercise and CGM Technology
CGM provides tremendous comfort in active lessons such as physical education, dancing, and ice skating. Continuous glucose monitoring allows individuals to see real-time glucose trends during exercise, making it easier to make informed decisions about carbohydrate intake or insulin adjustments without interrupting activity for fingerstick testing.
Many CGM systems allow for customizable alerts that can warn of dropping glucose levels during exercise, providing an opportunity to take action before hypoglycemia occurs. This technology empowers individuals with Type 1 diabetes to participate more confidently in sports and physical activities.
Preventing and Managing Hypoglycemia
Understanding Hypoglycemia Risk
Hypoglycemia, or low blood glucose (typically below 70 mg/dL), is one of the most common acute complications of Type 1 diabetes management. It can occur due to too much insulin, insufficient carbohydrate intake, increased physical activity, or alcohol consumption. Recognizing early symptoms and treating promptly is essential for safety.
Common symptoms of hypoglycemia include shakiness, sweating, rapid heartbeat, dizziness, hunger, irritability, confusion, and difficulty concentrating. Severe hypoglycemia can lead to seizures or loss of consciousness if untreated. Some individuals develop hypoglycemia unawareness, where they no longer experience typical warning symptoms, making CGM technology particularly valuable.
The 15-15 Rule
The standard treatment for hypoglycemia is the 15-15 rule: consume 15 grams of fast-acting carbohydrate, wait 15 minutes, and recheck blood glucose. If glucose remains below 70 mg/dL, repeat the treatment. Once glucose returns to normal, eat a small snack or meal to prevent recurrence, especially if the next meal is more than an hour away.
Examples of 15 grams of fast-acting carbohydrate include 4 glucose tablets, 4 ounces of fruit juice or regular soda, 1 tablespoon of honey or sugar, or glucose gel. Avoid treating with chocolate or foods high in fat, as fat slows carbohydrate absorption and delays glucose recovery.
Glucagon for Severe Hypoglycemia
The glucagon product available to individuals may differ based on coverage and cost, however those that do not require reconstitution are preferred for ease of administration, and clinicians should routinely review the individual’s access to glucagon as appropriate glucagon prescribing is low.
Glucagon is a hormone that raises blood glucose by triggering the liver to release stored glucose. It’s used as emergency treatment for severe hypoglycemia when the person is unconscious or unable to swallow safely. Newer glucagon formulations include nasal powder and auto-injectors that are easier to use than traditional glucagon emergency kits requiring reconstitution.
Family members, roommates, coworkers, and others who spend significant time with someone with Type 1 diabetes should know where glucagon is stored and how to administer it. Regular training and practice with demonstration devices helps ensure readiness in an emergency.
Nocturnal Hypoglycemia Prevention
Those using CGM with an alarm feature stated CGM reduces the loss of control at night and gives confidence and comfort. The families reported that they suffered a seriously degraded quality of sleep before using CGM, and families reported that they still woke up often but measuring became easier.
Nocturnal hypoglycemia is particularly dangerous because symptoms may not wake the person, or symptoms may be attributed to dreams. CGM alarms can alert individuals or caregivers to dropping glucose levels during sleep, allowing for intervention before severe hypoglycemia occurs. Setting appropriate alarm thresholds balances safety with sleep quality.
Managing Hyperglycemia and Diabetic Ketoacidosis
Understanding Hyperglycemia
Hyperglycemia, or high blood glucose, occurs when there is insufficient insulin to move glucose from the bloodstream into cells. Common causes include missed insulin doses, insufficient insulin dosing, illness or infection, stress, certain medications, and consuming more carbohydrates than planned. Persistent hyperglycemia can lead to both short-term and long-term complications.
Symptoms of hyperglycemia include increased thirst, frequent urination, fatigue, blurred vision, and headaches. If left untreated, hyperglycemia can progress to diabetic ketoacidosis (DKA), a serious and potentially life-threatening condition requiring immediate medical attention.
Correction Doses and Insulin Sensitivity Factor
The insulin sensitivity factor (ISF), also called correction factor, indicates how much one unit of rapid-acting insulin will lower blood glucose. For example, if someone’s ISF is 50, one unit of insulin will lower their blood glucose by approximately 50 mg/dL. This factor is used to calculate correction doses when blood glucose is above target.
Correction doses should be calculated carefully, taking into account insulin on board (active insulin from previous doses) to avoid insulin stacking and subsequent hypoglycemia. Most insulin pumps and some smart insulin pens automatically calculate recommended correction doses based on current glucose, target glucose, ISF, and insulin on board.
Sick Day Management
Illness and infection increase stress hormones that raise blood glucose and increase insulin requirements. Even if appetite is reduced and food intake is minimal, insulin is still necessary and often needs to be increased during illness. Never stop taking insulin, even when unable to eat normally.
During illness, check blood glucose and ketones more frequently (every 2-4 hours). If blood glucose is above 250 mg/dL, check for ketones using urine strips or a blood ketone meter. The presence of moderate to large ketones requires immediate action, including additional insulin, increased fluid intake, and potentially medical attention.
Recognizing and Treating Diabetic Ketoacidosis
Diabetic ketoacidosis occurs when the body breaks down fat for energy due to insufficient insulin, producing ketones that make the blood acidic. DKA is a medical emergency requiring immediate hospital treatment. Warning signs include blood glucose above 250 mg/dL with moderate to large ketones, nausea and vomiting, abdominal pain, fruity-smelling breath, rapid breathing, confusion, and extreme fatigue.
DKA can develop rapidly, sometimes within hours. Anyone experiencing these symptoms should seek emergency medical care immediately. Prevention through consistent insulin administration, regular glucose monitoring, and prompt treatment of hyperglycemia is essential.
Time in Range: A Key Metric for Diabetes Management
What Is Time in Range?
Time in Range (TIR) refers to the percentage of time blood glucose levels remain within a target range, typically 70-180 mg/dL for most adults with diabetes. TIR has emerged as an important complement to HbA1c for assessing glycemic control. While HbA1c provides an average glucose level over 2-3 months, TIR shows how much time glucose levels are actually in the healthy range.
The time in range improved from 18% with SMBG to 74% with the CGM device. Research shows that higher TIR is associated with lower risk of diabetes complications. The general goal for most adults with Type 1 diabetes is to achieve TIR greater than 70%, with less than 4% time below range and less than 25% time above range.
Understanding the Ambulatory Glucose Profile
The Ambulatory Glucose Profile (AGP) is a standardized report that summarizes CGM data in an easy-to-interpret visual format. It shows glucose patterns over time, including median glucose, glucose variability, and time spent in different glucose ranges. The AGP helps identify patterns such as overnight lows, post-meal highs, or consistent hyperglycemia at certain times of day.
Healthcare providers use AGP reports to make informed recommendations about insulin adjustments, meal timing, and other management strategies. Individuals can also learn to interpret their own AGP data to make day-to-day management decisions and identify areas for improvement.
Reducing Glucose Variability
The CoV, a measure of glucose variability, decreased from 39% to 29% after CGM implementation, meeting the goal of below 36%. Glucose variability refers to the fluctuations in blood glucose levels throughout the day. High variability, even with good average glucose levels, is associated with increased risk of complications and reduced quality of life.
Strategies to reduce glucose variability include consistent meal timing and carbohydrate intake, appropriate insulin-to-carbohydrate ratios, proper insulin timing relative to meals, regular physical activity, stress management, and adequate sleep. CGM data helps identify sources of variability and track improvement over time.
Emerging Technologies and Future Directions
Smart Insulin Pens
Smart insulin pens and pen caps represent an important advancement for individuals using multiple daily injections rather than insulin pumps. These devices automatically record insulin doses, timing, and amounts, syncing the data to smartphone apps. This technology helps prevent missed doses, reduces insulin stacking, and provides valuable data for healthcare providers.
Some smart pen systems integrate with CGM data to provide dose recommendations based on current glucose levels, insulin on board, and individual settings. This integration brings some of the benefits of automated insulin delivery to those who prefer injections over pump therapy.
Next-Generation CGM Sensors
Sensor accuracy continues to improve, with the latest generation of CGMs like Dexcom G7 and FreeStyle Libre 3 offering shorter warm-up times, better accuracy, and direct smartphone integration. Ongoing improvements in sensor technology focus on increased accuracy, longer wear time, smaller size, and reduced cost.
Future CGM systems may include implantable sensors lasting six months or longer, eliminating the need for frequent sensor changes. Research is also exploring non-invasive glucose monitoring technologies that don’t require sensor insertion under the skin, though these remain in development stages.
Disease-Modifying Therapies
A major breakthrough came with the FDA approval of Tzield (teplizumab), an anti-CD3 monoclonal antibody that can delay the onset of Type 1 in high-risk individuals, with trials showing this therapy can postpone the clinical manifestation of the disease by up to three years. Teplizumab, a humanized CD3-directed monoclonal antibody, has been approved as a treatment to delay the progression of T1DM.
This represents a paradigm shift from purely managing symptoms to potentially modifying disease progression. While not a cure, disease-modifying therapies offer hope for preserving beta cell function and delaying or preventing Type 1 diabetes onset in at-risk individuals.
Beta Cell Replacement Therapy
Researchers are exploring stem cell-derived beta cell transplants with companies like ViaCyte and Vertex Pharmaceuticals leading the charge, and in a landmark 2024 study encapsulated stem cell implants restored insulin production in a small cohort of patients without the need for continuous immunosuppression.
Beta cell replacement through pancreas transplantation or islet cell transplantation has been available for select patients, but requires lifelong immunosuppression. New approaches using encapsulated cells or genetically modified cells that evade immune detection may eventually provide insulin independence without immunosuppression, though this remains experimental.
Psychosocial Aspects of Diabetes Management
Diabetes Distress and Burnout
Living with Type 1 diabetes requires constant vigilance and decision-making, which can lead to diabetes distress and burnout. Diabetes distress refers to the emotional burden and worry related to managing diabetes, including concerns about complications, frustration with blood glucose fluctuations, and feeling overwhelmed by the demands of self-care.
Recognizing and addressing diabetes distress is essential for long-term management success. Healthcare providers should routinely screen for diabetes distress and provide support or referrals to mental health professionals when needed. Peer support groups, diabetes education programs, and counseling can help individuals develop coping strategies.
Technology and Mental Health
The constant monitoring and stream of data associated with CGMs can exacerbate diabetes-related stress and cause anxiety and decision paralysis, increasing the emotional burden for people with diabetes. While diabetes technology offers many benefits, it can also contribute to information overload and alert fatigue.
Finding the right balance with technology use is important. This may include customizing alert settings to reduce alarm fatigue, taking occasional “technology breaks” when safe to do so, and focusing on overall trends rather than individual glucose readings. Working with healthcare providers to set realistic expectations and goals helps prevent perfectionism and burnout.
Social Support and Diabetes Management
Families noted that children did not want to talk about their diabetes and CGM at first and hid them, however children usually received positive and supportive reactions about diabetes and CGM from their friends. Social support from family, friends, and the diabetes community plays a crucial role in successful management.
Educating family members and close friends about Type 1 diabetes, including how to recognize and treat hypoglycemia, helps create a supportive environment. Many individuals benefit from connecting with others who have Type 1 diabetes through support groups, online communities, or diabetes camps and events.
Shared Decision-Making
Healthcare professionals are increasingly adopting shared decision-making models that involve patients in choosing devices, medications, and lifestyle strategies, which improves treatment satisfaction and adherence especially in adolescents and young adults. Effective diabetes care requires collaboration between individuals and their healthcare teams.
Shared decision-making respects individual preferences, values, and life circumstances while incorporating clinical expertise and evidence-based recommendations. This approach recognizes that the person with diabetes is the expert on their own life and experiences, while healthcare providers contribute medical knowledge and guidance.
Special Considerations for Different Life Stages
Children and Adolescents
Managing Type 1 diabetes in children presents unique challenges, including unpredictable eating patterns, variable activity levels, growth and development, and the need for parental involvement. CGM technology has been particularly beneficial for pediatric populations, providing parents and caregivers with remote monitoring capabilities and alerts for concerning glucose levels.
Remote monitoring together with an alarm system also help teachers to reduce their worries about diabetes care at school. School management of diabetes requires collaboration between parents, school nurses, teachers, and administrators to ensure safe and effective care during school hours.
As children grow into adolescence, gradually transitioning diabetes management responsibilities from parents to the teen is important for developing independence and self-management skills. However, continued parental involvement and supervision remains important throughout adolescence, as this age group faces unique challenges including hormonal changes, irregular schedules, and psychosocial pressures.
Pregnancy and Type 1 Diabetes
All pregnant individuals with diabetes should monitor fasting, preprandial, and postprandial blood glucose levels, and CGM use is recommended for pregnant individuals with type 1 diabetes. Pregnancy requires tighter glucose control than usual, with target ranges typically 70-95 mg/dL fasting and less than 120-140 mg/dL one to two hours after meals.
Insulin requirements change dramatically throughout pregnancy, typically increasing significantly in the second and third trimesters. Frequent monitoring and insulin adjustments are necessary. Preconception planning and early prenatal care are essential for optimizing outcomes for both mother and baby.
Older Adults
Older adults with Type 1 diabetes may face additional challenges including other chronic health conditions, cognitive changes, physical limitations, and increased risk of hypoglycemia. Individualized glycemic targets that balance benefits of glucose control with risks of hypoglycemia are particularly important in this population.
CGM technology can be especially valuable for older adults at risk for hypoglycemia unawareness or those living alone. Simplified diabetes management regimens and involvement of caregivers or family members may be necessary to ensure safe and effective care.
Access and Equity in Diabetes Technology
Insurance Coverage and Cost Barriers
A CGM costs more than using a standard glucose meter but it may be covered by your health insurance, and you might be able to get financial help for diabetes care from your health insurance or other resources, so check with your health insurance plan or Medicare to see if the costs will be covered.
Insurance coverage in the United States for devices is highly variable and challenging to navigate, and maybe unaffordable for some patients due to high copays or coverage issues. Cost remains a significant barrier to accessing diabetes technology for many individuals, contributing to disparities in diabetes outcomes.
The most prominent issue was the economic burden of CGM, though families accept this burden even though it is challenging as their experiences in using CGM are positive and they feel that CGM is necessary for T1D management. Patient assistance programs, manufacturer discount programs, and advocacy for improved insurance coverage are important for expanding access.
Health Equity Considerations
Although CGMs have revolutionised diabetes management and diabetes self-management, barriers exist to accessing this technology particularly in low- and middle-income countries, with insurance coverage limiting access to CGMs and related supplies in higher-income settings, and affordability of devices and healthcare infrastructure challenges limiting access in LMICs.
Addressing health equity in diabetes care requires systemic changes including improved insurance coverage policies, reduced device costs, culturally appropriate education and support, and addressing social determinants of health that impact diabetes management. Healthcare providers and diabetes organizations must advocate for policies that ensure all individuals with Type 1 diabetes have access to the tools and support they need.
Telemedicine and Remote Care
Telemedicine initially a stopgap during the pandemic has now become a staple, with many endocrinology practices leveraging platforms like Doximity Dialer and Amwell to follow up with patients, review glucose trends, and adjust medications all without in-person visits. Telemedicine has expanded access to specialized diabetes care, particularly for individuals in rural areas or those with transportation barriers.
Remote data sharing from CGM systems and insulin pumps allows healthcare providers to review glucose patterns and make recommendations between office visits. This more frequent touchpoint can lead to faster problem-solving and improved outcomes. However, ensuring equitable access to telemedicine requires addressing digital literacy and internet access barriers.
Working with Your Healthcare Team
The Importance of Specialized Care
Comprehensive Type 1 diabetes care involves a multidisciplinary team including endocrinologists, certified diabetes care and education specialists, registered dietitians, mental health professionals, and primary care providers. Certified Diabetes Care and Education Specialists now often act as care coordinators helping bridge gaps between endocrinologists, primary care providers, behavioral health teams, and patients, with interdisciplinary care shown to reduce hospitalizations and improve long-term outcomes.
Regular appointments with an endocrinologist or diabetes specialist are essential for optimizing management, adjusting treatment plans, screening for complications, and staying current with new technologies and therapies. Most individuals with Type 1 diabetes benefit from quarterly visits, though more frequent contact may be needed during periods of change or difficulty.
Diabetes Education and Self-Management Training
Diabetes self-management education and support (DSMES) provides the knowledge and skills necessary for effective diabetes management. Topics covered include glucose monitoring, insulin administration, carbohydrate counting, hypoglycemia prevention and treatment, sick day management, and problem-solving skills.
DSMES is not a one-time event but an ongoing process. Needs change over time with new life stages, new technologies, and evolving treatment goals. Regular participation in diabetes education helps individuals stay current with best practices and maintain motivation for self-care.
Preparing for Medical Appointments
Making the most of healthcare appointments requires preparation. Before appointments, download and review CGM and insulin pump data, note any patterns or concerns, prepare questions, and bring a list of current medications and supplies. Many individuals find it helpful to keep a running list of questions between appointments.
During appointments, be honest about challenges with diabetes management, including missed doses, difficulty affording supplies, or emotional struggles. Healthcare providers can only help address problems they know about. Taking notes during appointments or bringing a support person can help remember recommendations and instructions.
Long-Term Complication Prevention and Screening
Understanding Diabetes Complications
Long-term complications of diabetes result from prolonged exposure to elevated blood glucose levels and include microvascular complications (affecting small blood vessels) such as retinopathy, nephropathy, and neuropathy, as well as macrovascular complications (affecting large blood vessels) such as cardiovascular disease, stroke, and peripheral artery disease.
The good news is that maintaining blood glucose levels as close to target as safely possible significantly reduces the risk of developing these complications. Regular screening allows for early detection and intervention, which can prevent or slow progression of complications.
Recommended Screening Schedule
Annual screening for diabetes complications should begin five years after Type 1 diabetes diagnosis for adults, or at puberty if diabetes was diagnosed in childhood. Recommended screenings include dilated eye exams to check for retinopathy, urine tests and blood tests to assess kidney function, foot exams to check for neuropathy and circulation problems, and lipid panels and blood pressure monitoring to assess cardiovascular risk.
Additional screenings may be recommended based on individual risk factors, including thyroid function tests (as autoimmune thyroid disease is more common in people with Type 1 diabetes) and celiac disease screening. Following recommended screening schedules allows for early intervention if complications begin to develop.
Cardiovascular Health
Cardiovascular disease is the leading cause of death in people with diabetes. In addition to glucose control, managing other cardiovascular risk factors is essential. This includes maintaining healthy blood pressure (target generally less than 130/80 mmHg), managing cholesterol levels with statin therapy when indicated, not smoking, maintaining a healthy weight, and engaging in regular physical activity.
Some individuals with Type 1 diabetes may benefit from low-dose aspirin therapy for cardiovascular protection, though this should be discussed with healthcare providers based on individual risk factors. Regular cardiovascular screening and risk assessment help guide preventive interventions.
Practical Tips for Daily Diabetes Management
Establishing Routines
Consistent routines help make diabetes management more automatic and reduce the mental burden of constant decision-making. This might include checking glucose at the same times each day, taking insulin at consistent times relative to meals, keeping diabetes supplies in the same locations, and scheduling regular times for reviewing glucose data and adjusting management strategies.
However, routines should be flexible enough to accommodate real life. The goal is to create helpful habits without becoming rigid or allowing diabetes to completely dictate daily schedules. Finding the right balance between structure and flexibility is key to sustainable long-term management.
Keeping Adequate Supplies
Running out of essential diabetes supplies can be dangerous. Maintaining adequate supplies of insulin, test strips, CGM sensors, pump supplies, lancets, and glucose tablets or other fast-acting carbohydrates is essential. Many people find it helpful to keep backup supplies in multiple locations such as home, work, car, and travel bags.
Setting up automatic refills for prescriptions and ordering supplies before running out helps prevent gaps in availability. Keeping a list of prescription information, including medication names, doses, and pharmacy contact information, makes reordering easier and ensures continuity of care when traveling or changing healthcare providers.
Traveling with Type 1 Diabetes
Traveling requires extra planning but should not be avoided. When traveling, pack at least twice as much insulin and supplies as expected to need, carry supplies in carry-on luggage rather than checked bags, bring a letter from your healthcare provider explaining your need for diabetes supplies and devices, and research medical facilities at your destination in case of emergency.
Time zone changes may require insulin dose adjustments, particularly for long-acting insulin. Discussing travel plans with healthcare providers before departure helps ensure safe management during the trip. Many people find it helpful to wear medical identification jewelry indicating they have Type 1 diabetes.
Problem-Solving Skills
Effective diabetes management requires strong problem-solving skills. When blood glucose patterns are not as expected, systematic troubleshooting helps identify causes and solutions. This might involve reviewing food records, insulin doses, activity levels, stress, illness, or other factors that could be affecting glucose levels.
Keeping records of changes made to diabetes management and their effects helps identify what works and what doesn’t. Working with healthcare providers to develop problem-solving strategies builds confidence and competence in managing unexpected situations.
Conclusion: Empowering Effective Diabetes Management
The face of Type 1 Diabetes Management is transforming thanks to technological, pharmacological, and behavioral innovations, with clinicians who stay updated on these advancements better positioned to offer comprehensive individualized care, and although challenges remain the toolkit for managing Type 1 Diabetes in 2025 is more robust than ever promising brighter outcomes for patients navigating this lifelong condition.
Managing blood glucose in Type 1 diabetes requires a comprehensive approach that integrates advanced technology, individualized insulin therapy, thoughtful nutrition planning, regular physical activity, and strong psychosocial support. CGM systems provide the information necessary to create individualized therapeutic plans and empower people with DM with real-time information and data that allows them to take an active role in their diabetes management at home.
The evolution of diabetes technology, particularly continuous glucose monitoring and automated insulin delivery systems, has revolutionized Type 1 diabetes management. These tools provide unprecedented insight into glucose patterns and reduce the burden of constant decision-making. However, technology is most effective when combined with solid diabetes education, supportive healthcare teams, and attention to the psychosocial aspects of living with a chronic condition.
Every individual with Type 1 diabetes has unique needs, preferences, and circumstances. What works well for one person may not be ideal for another. The key is finding the combination of strategies, tools, and support that enables each person to achieve their health goals while maintaining quality of life. With continued advances in treatment options and growing understanding of optimal management strategies, the future for individuals with Type 1 diabetes continues to improve.
For more information about diabetes management and continuous glucose monitoring, visit the American Diabetes Association, the National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes in Control, the Association of Diabetes Care & Education Specialists, and the International Diabetes Federation.